Skip to main content
NewslettersWatchlist

Fibrogen Inc CS(FGEN-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Fibrogen Inc CS

409 ILLINOIS STREET
SAN FRANCISCO CA 94158 USA
P: 415-978-1200
F: 415-978-1902
http://www.fibrogen.com

Profile

FibroGen, Inc. is a research-based biotechnology company. It is focused on the discovery, development, and commercialization of therapeutic agents for treatment of anemia, fibrosis, cancer, and other serious unmet medical needs. The Company develops Roxadustat that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; and FG-3019 which is in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and liver fibrosis. FibroGen, Inc. is headquartered in San Francisco, California.

Key Executives

NameTitle
Christine ChungSenior VP, Geographical
Thane WettigCEO/Director
Juan GrahamCFO/Chief Accounting Officer
Deyaa AdibChief Medical Officer/Senior VP

More from The Globe

opinion
This Canadian aerospace stock deserves a place on your watch list
Robert Tattersall
The close: TSX pulls back as resource shares slide; Nvidia rallies in post market on earnings beat
Traders work on the floor of the New York Stock Exchange during morning trading on May 17.
What every Canadian investor needs to know today
A screen tracks NVIDIA Corp. as a trader works on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 23, 2023. REUTERS/Brendan McDermid/File Photo
Earnings from AI-heavyweight Nvidia to test U.S. stocks’ record run
A sign is posted in front of Nvidia headquarters on May 21 in Santa Clara, California.
The close: S&P 500 and TSX squeak out record highs after Fed comments
The Art Deco facade of the original Toronto Stock Exchange building is seen on Bay Street in Toronto in January of 2019.
Before the Bell: What every Canadian investor needs to know today
Traders work on the floor of the New York Stock Exchange during morning trading on May 17, 2024 in New York City. Wall Street stocks opened little changed May 17 after pulling back from a record run where the Dow exceeded 40,000 points for the first time. Around 10 minutes into trading the Dow Jones Industrial Average was steady at 39,872.66. (Photo by ANGELA WEISS / AFP) (Photo by ANGELA WEISS/AFP via Getty Images)
ReconAfrica agrees to pay out more than $10-million over allegedly misleading disclosure
ReconAfrica oil drilling site in Namibia for Geoffrey York and Emma Graney story.
number cruncher
U.S technology stocks with earnings and price momentum
For Number Cruncher column in Globe Investor/ROB only.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.